金吾财讯 | 京东健康(06618)公布，截至2024年12月31日止年度的年度业绩。期内，归属于公司所有者年度盈利41.62亿元(人民币，下同)，同比增长94.31%；每股基本盈利1.32元，去年同期为0.69元。不派末期股息。期内，公司收入581.6亿元，同比增长8.65%。
公告指，总收入的增长主要是由于销售医药和健康产品所得商品收入增加6.9%至2024年的488亿元。商品收入的增长驱动力主要有活跃用户数量增加及用户的额外购买、医药和健康产品销售的线上渗透率不断提高及产品品类的丰富。
线上平台、数字化营销及其他服务所得服务收入增加18.9%至2024年的94亿元。公司服务收入的增长主要是由于数字化营销服务费增加，主要归因于平台上的广告主数量增加，这与公司平台的交易持续增长保持一致。
期内，毛利为133亿元，毛利率为22.9%，去年同期毛利率为为22.2%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.